Home LiteratureArticle Details
PMID: 3124736 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods.

Antimicrobial agents and chemotherapy ·Vol. 31 ·No. 11 ·1987-11-00 ·Pages 1697-702

Inderlied CB, Young LS, Yamada JK

Abstract

Various methods were used to determine the in vitro susceptibility of Mycobacterium avium complex strains isolated from patients with acquired immunodeficiency syndrome. Our results confirm the noted resistance of the M. avium complex to conventional antituberculosis agents. The procedures used were both agar dilution and broth dilution, including a commercially available radiometric system (BACTEC; Johnston Laboratories, Towson, Md.). In general, all strains were more resistant by an agar dilution procedure than by a broth dilution procedure. Radiometric data were analyzed by defining a value, termed T100, which provides a discrete MIC. The broth (radiometric) procedure is reproducible and convenient for screening antimicrobial agents for in vitro activity and assessing potential therapeutic efficacy. Nevertheless, there is no standard procedure for determining the in vitro susceptibility of the M. avium complex, and appropriate clinical correlation studies are needed to accurately assess the clinical relevance of any in vitro result.

MeSH Terms
Amikacin/pharmacology Carbon Dioxide/metabolism Ciprofloxacin/pharmacology Microbial Sensitivity Tests/methods Mycobacterium avium/drug effects
Chemicals
Carbon Dioxide Ciprofloxacin Amikacin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Inderlied C B
Department of Pathology, University of Southern California, Children's Hospital of Los Angeles 90027.
Young L S
Yamada J K
References (19)
19 references, click to expand
  1. Non-photochromogenic mycobacteria serotype Davis. The inhomogeneity within the serological group and the relationship to Mycobacterium avium.
    Acta Pathol Microbiol Scand B Microbiol Immunol. 1970;78(5):619-31 PMID: 4322001
  2. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.
    Am J Med. 1987 Apr 27;82(4A):23-6 PMID: 3107379
  3. Nontuberculous mycobacteria and associated diseases.
    Am Rev Respir Dis. 1979 Jan;119(1):107-59 PMID: 369415
  4. Long-term results of medical treatment in Mycobacterium intracellulare infection.
    Am J Med. 1979 Sep;67(3):449-53 PMID: 474589
  5. Rapid radiometric method for determining drug susceptibility of Mycobacterium avium-intracellulare.
    Antimicrob Agents Chemother. 1981 Apr;19(4):534-9 PMID: 7247376
  6. Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?
    Antimicrob Agents Chemother. 1981 Nov;20(5):666-77 PMID: 6798925
  7. Treatment of disease due to Mycobacterium intracellulare.
    Rev Infect Dis. 1981 Sep-Oct;3(5):1052-9 PMID: 7339803
  8. Isolation of nontuberculous mycobacteria in the United States, 1980.
    J Infect Dis. 1982 Dec;146(6):829-33 PMID: 6815283
  9. Activity of amikacin against Mycobacteria in vitro and in murine tuberculosis.
    Tubercle. 1982 Sep;63(3):201-8 PMID: 6817487
  10. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.
    Antimicrob Agents Chemother. 1984 Jul;26(1):94-6 PMID: 6236748
  11. Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods.
    J Clin Microbiol. 1985 Dec;22(6):919-23 PMID: 3934209
  12. Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods.
    Antimicrob Agents Chemother. 1985 Oct;28(4):570-5 PMID: 4073881
  13. Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.
    Antimicrob Agents Chemother. 1986 Mar;29(3):386-8 PMID: 2940969
  14. Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome.
    Diagn Microbiol Infect Dis. 1986 Sep;5(3):215-20 PMID: 3757474
  15. Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex.
    Rev Infect Dis. 1986 Nov-Dec;8(6):1024-33 PMID: 3541122
  16. Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 1986 Dec;30(6):927-32 PMID: 3101588
  17. Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome.
    Antimicrob Agents Chemother. 1986 Dec;30(6):955-7 PMID: 3813519
  18. In vitro activity of ciprofloxacin and ofloxacin against the Mycobacterium avium-intracellulare complex.
    Diagn Microbiol Infect Dis. 1987 May;7(1):89-91 PMID: 3121243
  19. Rapid radiometric susceptibility testing of Mycobacterium tuberculosis.
    Am Rev Respir Dis. 1978 Apr;117(4):631-7 PMID: 417650
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1987-11-00
Pages
1697-702
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC175023
Subset
IM
Grants
NIAID NIH HHS · AI-42545 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]